Net Sales in the Field Sample Clauses

The 'Net Sales in the Field' clause defines how net sales are calculated specifically for products sold within a particular industry or application area, often referred to as the 'field.' This clause typically outlines which revenues are included or excluded from net sales, such as deducting returns, discounts, or taxes, and clarifies that only sales relevant to the agreed-upon field are counted. Its core function is to ensure that royalty payments or other financial obligations are accurately based on sales that are directly related to the licensed technology or product's intended use, thereby preventing disputes over what constitutes qualifying sales.
Net Sales in the Field. Vertex shall pay to CFFT the following royalties on annual Net Sales of each Drug Product: 4% [***] Net Sales [***] Net Sales [***] Net Sales [***] [***] Net Sales under this Section 5.3.1 shall not in any event include any Net Sales of Drug Products which are the subject of the royalty obligations set forth in Sections 5.3.2, 10.5.4, 10.5.5, and 10.5.6 hereof.
View SourceView Similar (6)
Net Sales in the Field. (a) Vertex shall pay to CFFT the following royalties on Net Sales [***]: • [***] • [***] • [***]; [***]. (b) [***]: • [***] • [***]. [***]. (c) [***]: • [***] • [***]. [***].
View SourceView Similar (5)
Net Sales in the Field. Vertex shall pay to CFFT the following royalties on annual Net Sales of each Drug Product:
View SourceView Similar (2)
Net Sales in the Field 
View SourceView Similar (5)

Related to Net Sales in the Field

  • Net Sales The term “

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.

  • Licensed Product The term “Licensed Product” shall mean any product (a) the manufacture, use, importation, sale or offer for sale of which would, in the absence of the license granted by this Agreement, infringe a Valid Claim of any of the Licensed Patent Rights, or (b) that is comprised of, utilizes or incorporates Licensed Biological Materials, or (c) that is discovered, developed or made using a Licensed Process.

  • Royalty Term On a country-by-country and Licensed Product-by-Licensed Product basis, royalty payments in the Territory shall commence upon the first commercial sale of such Licensed Product, whether such sale is to a Public Purchaser, Governmental Authority or private entity or person and whether such sale is made under an EUA or Key Approval, in such country in the Territory and will terminate upon the later of: (a) the expiration, invalidation or abandonment date of the last Valid Claim of the Patents in the country of sale or manufacture of such Licensed Product in the Territory or (b) expiration of regulatory exclusivity of such Licensed Product in such country of sale in the Territory (the “Royalty Term”).